The authors reply

New England Journal of Medicine

Volumn 374, Issue 21, 2016, Pages 2094-2095

  Grams, Morgan E ^a   Garg, Amit X ^b   Lentine, Krista L ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FEMALE; HUMAN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; RISK ASSESSMENT;

FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; RISK ASSESSMENT;

EID: 84969750855     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1603007     Document Type: Letter

References (5)

1. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS. Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 2009; 169: 342-50.
2. Muzaale AD, Massie AB, Wang MC, et al. Risk of end-stage renal disease following live kidney donation. JAMA 2014; 311: 579-86.
3. Mjøen G, Hallan S, Hartmann A, et al. Long-term risks for kidney donors. Kidney Int 2014; 86: 162-7.
4. Huang N, Foster MC, Lentine KL, et al. Estimated GFR for living kidney donor evaluation. Am J Transplant 2016; 16: 171-80.
5. Kidney Disease: Improving Global Outcomes (KDIGO). KDIGO clinical practice guideline on the evaluation and followup care of living kidney donors (draft). 2015 (http://kdigo.org/home/guidelines/livingdonor/).